High incidence of stroke in COVID-19 patients

Area of Science:

• Neurology
• Infectious Diseases
• Cardiovascular Medicine

Background:

• The COVID-19 pandemic has presented numerous clinical challenges beyond respiratory illness.
• Emerging evidence suggests a link between SARS-CoV-2 infection and cerebrovascular events, including stroke.
• Understanding the specific risks and indicators for stroke in COVID-19 patients is crucial for timely intervention.

Purpose of the Study:

• To investigate the incidence of stroke in patients diagnosed with COVID-19.
• To identify potential biomarkers associated with stroke occurrence in this patient cohort.
• To highlight the need for established protocols for managing acute stroke in COVID-19 patients.

Main Methods:

• Retrospective analysis of clinical data from 11 patients with COVID-19 and concurrent stroke.
• Comparison of stroke incidence in COVID-19 patients against general population averages.
• Analysis of D-dimer levels in stroke patients compared to non-stroke COVID-19 patients.

Main Results:

• A statistically significant higher incidence of stroke was observed in COVID-19 patients (P=0.003).
• Patients experiencing stroke had significantly elevated D-dimer levels compared to other COVID-19 patients (P=0.004).
• Elevated D-dimer levels were identified as a potential early warning indicator for cerebral infarction.

Conclusions:

• COVID-19 is associated with an increased risk of stroke.
• D-dimer serves as a valuable early warning marker for cerebral infarction in COVID-19 patients.
• Developing specific response plans for acute stroke management in COVID-19 is critical.